Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pancrelipase microtablets in infants and toddlers with CF
NCT00217204Phase 2Completed
- Sponsor
- McNeil Laboratories
- Start
- Jul 2005
- Modality
- Replacement Enzymes
01
Overview
A Phase 2 trial of pancrelipase in cystic fibrosis (CF), exocrine pancreatic insufficiency (EPI), sponsored by McNeil Laboratories. Started Jul 2005; status: completed.
02
Drugs
pancrelipase
03
Conditions
cystic fibrosis (CF)exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00217204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217204.